inquiry
Leave Your Message

PRL-8-53 Nootropic Compound - Memory Enhancer from China Factory | Suppliers of 51352-87-5, High Purity & Quality

,

Product Name: PRL-8-53

,

CAS: 51352-87-5

,

Molecular Formula: C18H22ClNO2

,

Molecular Weight: 319.83 g/mol

,

EINECS Number: N/A

,

Appearance: White to off-white powder

,

Purity: ≥98%

,

Packaging: Available in various sizes: 1kg, 5kg, 10kg, 50kg, and 100kg (custom packaging options are also available)

,

Origin: China

,

As a leading supplier and factory of high-quality PRL-8-53 in China, we ensure that our product meets stringent purity levels of ≥98%. This versatile compound, known for its effectiveness, is offered in a convenient white to off-white powder form. With flexible packaging options ranging from 1kg to 100kg, we cater to various customer needs while maintaining the integrity and quality of our products. Trust us as your go-to supplier in the chemical industry.

,

    Brief Introduction

    PRL-8-53 is an experimental compound which many believe to be one of the most effective memory boosters available. It is a nootropic research chemical derived from benzoic acid and phenylmethylamine with memory-enhancing effects, used in neuroscience research related to memory enhancement and protection against memory impairment.

    Chemical Name: Methyl 3-(2-(benzyl(methyl)amino)ethyl)benzoate hydrochloride
    Classification: Phenethylamine derivative · Psychotropic agent · Nootropic
    Molecular Formula: C₁₈H₂₂ClNO₂  |  Molecular Weight: 319.83 g/mol

    PRL-8-53's structure and mechanism differ from classic racetam compounds, offering a unique molecular tool for cognitive function research. This compound has garnered continued research interest due to its significant memory retention-enhancing effects demonstrated in a human double-blind clinical trial published in 1978.

    🔬

    Key Scientific Value & Findings

    A double-blind clinical trial published in the journal Psychopharmacology in 1978 investigated the effects of PRL-8-53 on learning and retention of verbal information in human subjects. Key findings include:

    • 🧠
      Significant Memory Retention Enhancement: PRL-8-53 produced a statistically significant positive effect on the retention of verbal information (most P values better than 0.01, some better than 0.001).
    • 📈
      Mild Improvement in Acquisition: The drug caused slight improvement in learning acquisition.
    • No Motor/Sensory Interference: No significant changes were found for either visual reaction time or motor control after drug treatment compared with placebo values.
    • 🔗
      Phenethylamine Derivative Structure: PRL-8-53 is a derivative of 2-phenylethylamine, a structural scaffold with some relation to endogenous neurotransmitters such as dopamine and norepinephrine, though its precise mechanism of action has not been fully elucidated.
    • 💊
      Oral Activity: PRL-8-53 has been confirmed as an orally active psychotropic agent, with the original human study employing oral administration.
    • 📚
      Historical Literature Position: A 1983 Chinese-language publication listed PRL-8-53 alongside compounds like methylphenidate as memory-enhancing agents, indicating its place in nootropic research history.

    Our Supply & Service Advantages

    ❓ Frequently Asked Questions (FAQ)
    Q What is PRL-8-53?
    PRL-8-53 is an experimental nootropic research chemical derived from benzoic acid and phenylmethylamine. Its chemical name is Methyl 3-(2-(benzyl(methyl)amino)ethyl)benzoate hydrochloride, and it is classified as a phenethylamine derivative and psychotropic agent investigated for memory-enhancing properties.
    Q What evidence supports PRL-8-53's memory-enhancing effects?
    A double-blind clinical trial published in the journal Psychopharmacology in 1978 demonstrated statistically significant improvements in verbal information retention among human subjects, with most P values better than 0.01 and some better than 0.001.
    Q How does PRL-8-53 differ from racetam nootropics?
    Unlike classic racetam compounds (such as piracetam or aniracetam), PRL-8-53 is a phenethylamine derivative with a structurally distinct molecular scaffold. Its mechanism of action and chemical structure are unique, offering researchers a different molecular tool for studying cognitive function.
    Q Is PRL-8-53 orally active?
    Yes. PRL-8-53 has been confirmed as an orally active compound. The original 1978 human clinical study administered PRL-8-53 orally to participants, confirming its bioavailability via this route.
    Q Does PRL-8-53 affect motor control or reaction time?
    According to the 1978 clinical study, no significant changes were observed in visual reaction time or motor control following PRL-8-53 treatment compared to placebo, suggesting it does not interfere with these sensory-motor functions at studied doses.
    Q What is the molecular formula and weight of PRL-8-53?
    PRL-8-53 has a molecular formula of C₁₈H₂₂ClNO₂ and a molecular weight of 319.83 g/mol. It is structurally related to 2-phenylethylamine, sharing some scaffold similarities with endogenous neurotransmitters such as dopamine and norepinephrine.

    Leave Your Message